MYELIN REPAIR FOUNDATION INC
Data sourced from IRS 990 public filings
MYELIN REPAIR FOUNDATION INC Accelerating the development of new therapeutics to prevent or repair damage to myelin caused by Multiple Sclerosis. Myelin Repair Foundation is helping to identify biomarkers of myelin repair for use in myelin repair drug development and clinical trials
MYELIN REPAIR FOUNDATION INC has received 19 grants from 9 known foundation funders. Revenue increased from $266,071 in 2023 to $267,774 in 2024. Most recent reported revenue: $267,774.
Annual Revenue
$267,774
Known Funders
9
Grants Received
19
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $267,774 | $512,994 | $877,106 |
| 2023 | $266,071 | $503,704 | $1,295,871 |
| 2022 | $552,239 | $463,359 | $1,550,183 |
| 2021 | $285,427 | $538,950 | $1,330,627 |
| 2020 | $530,327 | $235,519 | $1,468,414 |
| 2019 | $266,648 | $554,753 | $1,357,117 |
| 2018 | $294,685 | $538,400 | $1,552,624 |
| 2017 | $1,077,554 | $589,184 | $1,627,215 |
Top Funders
JACKSON, WY
SAN FRANCISCO, CA
JACKSON, WY
ST LOUIS, MO
FORT WORTH, TX
JACKSON, WY
CHICAGO, IL
YORKTOWN, VA
YORKTOWN, VA
YORKTOWN, VA
Key Personnel
From 2024 IRS 990 filing
Andy Cates
Director
Scott Johnson
CEO
Bobby Mehta
Director
Jim Gidwitz
Director
Eric Hsu
Director
Frequently Asked Questions
Other Nonprofits in California
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.